First Horizon Advisors, Inc. Organogenesis Holdings Inc. Transaction History

First Horizon Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$6.47 - $9.57 $5,732 - $8,479	-886 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$9.02 - $13.5 $6,295 - $9,423	698 Added 371.28%	886 $8,000
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $2,001 - $2,508	146 Added 347.62%	188 $2,000
Q3 2021 Nov 09, 2021	SELL	$13.71 - $17.18 $2,001 - $2,508	-146 Reduced 77.66%	42 $0
Q2 2021 Aug 09, 2021	BUY	$14.92 - $23.23 $2,804 - $4,367	188 New	188 $3,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $419M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.